by Truveta staff | Oct 28, 2024 | Research
Overall, the rate of hospitalizations associated with respiratory viruses decreased throughout September 2024 and into the first week of October. For infants and children aged 0-4 years old, respiratory virus-associated hospitalizations increased slightly by 2.9%...
by Truveta staff | Oct 10, 2024 | Data
The US market size for joint replacement is projected to balloon to nearly $38 billion by 2030, nearly doubling its 2022 value. The combination of an aging population, increasing rates of osteoarthritis and obesity, along with advancing technology, are all...
by Truveta News | Oct 9, 2024 | News
Today, Truveta was featured as #3 on LinkedIn’s inaugural Top Startups in Seattle list. The ranking highlights ten growing start-up companies in the Seattle area. Last month, Truveta was also included on the national LinkedIn’s Top Startups list for 2024, which...
by Truveta staff | Sep 26, 2024 | Technology
Despite advances in guideline-directed medical therapy, heart failure (HF) readmission rates have worsened over the past decade. Optimizing acute inpatient decongestion is critical in mitigating HF morbidity and mortality, but few new treatment strategies have emerged...
by Truveta staff | Sep 19, 2024 | Research
Overall, the rate of hospitalizations associated with respiratory viruses remained stable throughout August 2024, with no change compared to July 2024. For infants and children aged 0-4 years old, respiratory virus-associated hospitalizations increased significantly...
